The latest immunotherapy news and developments
Programming cells to target brain tumours
Glioblastoma is the most common and most aggressive primary brain tumour, with an average survival…
Browsing: Immunotherapy
Combination treatment improves response to immunotherapy for lung cancer
Researchers at the Francis Crick Institute, UK, in collaboration with Revolution Medicines, have tested a…
Five key factors predict the response of cancer patients to immunotherapy
Immunotherapy has transformed cancer treatment in recent years by enabling the immune system to attack…
ESMO 2024: Experimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase 1 trial
Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359),…
Gut bacteria influence responses to immunotherapy in patients with asbestos related cancer
A cancer study has found that certain gut bacteria may influence whether or not a…
Researchers develop nanostructures to improve immune response to cancer
Immune checkpoint blockade (ICB) is one of the primary methods of tumour immunotherapy. It involves reactivating…
Researchers reveal key LAG3 mechanisms that could transform cancer immunotherapy
Immune checkpoint inhibitors are a type of cancer treatment that helps the immune system attack…
Combo immunotherapy produces distinct waves of cancer-fighting T cells with each dose
A new tool for monitoring immune health patterns over time has revealed how a pair…
Small molecules, big impact: advancing immune checkpoint inhibitors for cancer
Recent research highlights an approach in cancer therapy with small molecule drugs targeting immune checkpoints.…
Targeting cancer with precision: neoantigen vaccines show promise
In an elegant fusion of science and medicine, neoantigen cancer vaccines are emerging as a…